Doutor Nedres Holdings Co., Ltd. achieved sales of \u00a542.5 billion (YoY +8.2%) and net income of \u00a52.7 billion (YoY +31.4%) in the first quarter of FY2027, maintaining strong performance. Segment-wise, both the coffee and restaurant businesses are expanding, reflecting robust results.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3087","jir_company_name":"Doutor Nedres Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-07-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/3087-20260713-01.pdf","jir_short_summary":"Doutor Nedres Holdings Co., Ltd. achieved sales of \u00a542.5 billion (YoY +8.2%) and net income of \u00a52.7 billion (YoY +31.4%) in the first quarter of FY2027, maintaining strong performance. Segment-wise, both the coffee and restaurant businesses are expanding, reflecting robust results.","jir_summary":"### Performance Overview\nThis fiscal period showed steady performance, with sales reaching \u00a542.5 billion (YoY +8.2%), operating income of \u00a53.7 billion (YoY +35.2%), and net income of \u00a52.7 billion (YoY +31.4%). Segment-wise, both the restaurant and coffee businesses continued to grow sales, with existing store sales remaining strong. The company expanded new stores and introduced high-value-added products, leading to the recovery of customer spending per visit and number of customers, resulting in increased sales and profits.\n\n### Outlook and Impact on Shareholders\nThe earnings forecast remains unchanged, with continued focus on sales expansion and cost management. Backed by the recovery trend post-COVID-19, the company will promote the recovery of existing store sales and new store openings to strengthen its earnings base. The dividend forecast is maintained at \u00a560 (up \u00a55 YoY), reflecting stable payout. investors can expect stable returns driven by steady performance and growth strategies.","jir_financial_highlights":"Sales: \u00a542.528 billion (YoY +8.2%)\nOperating Income: \u00a53.77 billion (YoY +35.2%)\nNet Income Attributable to Owners of the Parent: \u00a52.724 billion (YoY +31.4%)","jir_category":"","jir_hashtags":"#DoutorNedresHoldings, #IRFinancialResults, #JapanStocks","jir_key_figures":"Sales: \u00a542.528 billion (YoY +8.2%)\nNet Income Attributable to Owners of the Parent: \u00a52.724 billion (YoY +31.4%)\nFull-year Dividend Forecast: \u00a560 (YoY +\u00a55)","jir_meta_title":"\u3010Doutor Nedres Holdings Co., Ltd.\u3011 FY2027 Q1 Financial Results | Sales of \u00a542.5 billion (+8.2%)","jir_meta_description":"Doutor Nedres Holdings Co., Ltd. achieved sales of \u00a542.5 billion and net income of \u00a52.7 billion in the first quarter of FY2027. Segment-wise performance remains strong, with growth expected going forward.","jir_og_title":"\u3010Doutor Nedres Holdings\u3011 FY2027 Q1 Results | Sales of \u00a542.5 billion","jir_og_description":"Doutor Nedres achieved sales of \u00a542.5 billion and net income of \u00a52.7 billion in FY2027 Q1, maintaining solid performance. The company will continue its growth strategy.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9448,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-79878","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n